Winson Y. Cheung on Managing Side Effects for Patients on Checkpoint Inhibitors

Video

Winson Y. Cheung, MD, Medical Oncologist at the British Columbia Cancer Agency in Vancouver, discusses the nurse’s role in managing side effects for patients who are on checkpoint inhibitors.

In a study of patients with metastatic melanoma who have taken checkpoint inhibitors, Cheung found that the vast majority of patients experienced side effects of varying degrees, the most common being diarrhea and skin rash. As checkpoint inhibitors continue to expand in use to treat other cancer types, it is important that nurses are aware of the side effects and know how to best manage them.

Recent Videos
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Elizabeth Burton in an interview with Oncology Nursing News
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.